Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus

Clinical trial NCT06446310 · UNKNOWN

Trial details

NCT number: NCT06446310
Sponsor: Qilu Pharmaceutical (Hainan) Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Uremic Pruritus

Start date: 2024-06-18
Primary completion: 2025-02-21
Enrollment: 194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.